Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2024-07-24 Earnings Release
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Trading Update
Earnings Release Classification · 1% confidence The document is a short announcement dated July 24, 2024, titled 'Trading Update' providing 'unaudited trading update for the six months ended 30 June 2024 ("H1 2024")'. It gives key financial highlights (EBITDA growth expectation, cash generation) and states that the company 'expects to announce its unaudited results for H1 2024 on 17 September 2024'. Since this is a brief announcement providing preliminary results/updates ahead of the full report, it fits the definition of an Earnings Release (ER). It is not the comprehensive Interim Report (IR) itself, nor is it a mere announcement of a report's publication date (RPA), as it contains substantive financial updates. The presence of 'RNS Number' and the closing footer confirms it is a regulatory news service filing. H1 2024
2024-07-24 English
Upgraded Product launch and Contract Wins
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 8285W' and concludes with boilerplate text referencing 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This strongly indicates a general regulatory announcement or press release distributed via the RNS system. The content details a product launch and new contract wins, which are material operational updates but do not fit the specific definitions for 10-K, ER, IR, DIV, or DIRS. Since it is a general announcement distributed through the RNS mechanism and doesn't fit a more specific category like ER (Earnings Release) or CAP (Capital/Financing Update), the most appropriate classification is the general regulatory announcement category.
2024-07-18 English
Result of AGM and Voting Results
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it concerns the 'Result of AGM and Voting Results' for EKF Diagnostics Holdings plc. It details the voting outcomes for various resolutions presented at the Annual General Meeting (AGM). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the primary content is the voting result tabulation, not the AGM presentation materials (AGM-R) or the proxy solicitation materials (PSI). The RNS header confirms it is a regulatory announcement, but DVA is the most specific category.
2024-05-14 English
AGM Statement & Positive Q1 update (replacement)
AGM Information Classification · 1% confidence The document is an RNS announcement (RNS Number: 3610O) that explicitly states it is an 'AGM Statement & Positive Q1 Trading update' provided ahead of the company's Annual General Meeting ('AGM'). It contains an 'Executive Chair's AGM statement' which discusses Q1 trading performance. Since it is a statement delivered at the AGM, it directly relates to the AGM proceedings. Although it contains trading updates (which might suggest ER or MDA), the primary context and delivery mechanism is the AGM. Therefore, AGM-R (AGM Information) is the most appropriate classification, as it is the material presented during that meeting.
2024-05-14 English
AGM Statement & Positive Q1 Trading update
AGM Information Classification · 1% confidence The document is explicitly titled 'AGM Statement & Positive Q1 Trading update' and begins by stating it is an update provided ahead of the Annual General Meeting ('AGM') today. It contains a detailed 'Executive Chair's AGM statement' which reviews 2023 performance and provides a positive trading update for Q1 2024, including specific financial metrics (like adjusted EBITDA improvement and sales growth percentages). Since the document is a statement delivered at the AGM, it directly relates to the meeting proceedings and materials. While it contains trading updates, the primary context is the AGM. Therefore, it fits best under AGM Information (AGM-R). It is not a full 10-K, a standalone AR, or just an ER (as it's tied to the AGM).
2024-05-14 English
Posting of Annual Report & Notice of AGM
AGM Information Classification · 1% confidence The document is a regulatory announcement (RNS Number: 5356L) from EKF Diagnostics Holdings PLC. The title explicitly states "Posting of Annual Report & Accounts and Notice of AGM". The text confirms that the Annual Report and Accounts for the year ended 31 December 2023 and the Notice of the 2024 Annual General Meeting (AGM) have been published on the company website. Since the document itself is an announcement stating that the full reports are available elsewhere, and it specifically mentions the AGM Notice, it fits the criteria for a Report Publication Announcement (RPA) or potentially an AGM-R if the AGM Notice is the primary focus. However, because it announces the posting of *both* the Annual Report (which would typically be a 10-K or AR) and the AGM Notice, and it is a short announcement (4728 chars), the most accurate classification based on the 'MENU VS MEAL' rule is RPA, as it is announcing the publication of other documents. Given the strong mention of the AGM Notice, AGM-R is also a strong candidate, but RPA covers the act of announcing the publication of multiple reports/notices. Since the AGM Notice is a key component, and AGM-R covers AGM materials, I will prioritize the AGM aspect combined with the announcement nature. However, the definition for RPA is 'Announcement regarding the timing, release, or publication of company reports'. This document perfectly matches the RPA definition by announcing the posting of the Annual Report and the AGM Notice. I will select RPA as it covers the action described.
2024-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.